Cargando…
Does Monthly Dupilumab Therapy Maintain its Clinical Efficacy in Moderate-to-Severe Atopic Dermatitis?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419646/ https://www.ncbi.nlm.nih.gov/pubmed/34486254 http://dx.doi.org/10.4168/aair.2021.13.5.681 |
| _version_ | 1783748797042524160 |
|---|---|
| author | Kim, Su Min Park, Chang Ook |
| author_facet | Kim, Su Min Park, Chang Ook |
| author_sort | Kim, Su Min |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8419646 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84196462021-09-14 Does Monthly Dupilumab Therapy Maintain its Clinical Efficacy in Moderate-to-Severe Atopic Dermatitis? Kim, Su Min Park, Chang Ook Allergy Asthma Immunol Res Editorial The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2021-08-23 /pmc/articles/PMC8419646/ /pubmed/34486254 http://dx.doi.org/10.4168/aair.2021.13.5.681 Text en Copyright © 2021 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Kim, Su Min Park, Chang Ook Does Monthly Dupilumab Therapy Maintain its Clinical Efficacy in Moderate-to-Severe Atopic Dermatitis? |
| title | Does Monthly Dupilumab Therapy Maintain its Clinical Efficacy in Moderate-to-Severe Atopic Dermatitis? |
| title_full | Does Monthly Dupilumab Therapy Maintain its Clinical Efficacy in Moderate-to-Severe Atopic Dermatitis? |
| title_fullStr | Does Monthly Dupilumab Therapy Maintain its Clinical Efficacy in Moderate-to-Severe Atopic Dermatitis? |
| title_full_unstemmed | Does Monthly Dupilumab Therapy Maintain its Clinical Efficacy in Moderate-to-Severe Atopic Dermatitis? |
| title_short | Does Monthly Dupilumab Therapy Maintain its Clinical Efficacy in Moderate-to-Severe Atopic Dermatitis? |
| title_sort | does monthly dupilumab therapy maintain its clinical efficacy in moderate-to-severe atopic dermatitis? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419646/ https://www.ncbi.nlm.nih.gov/pubmed/34486254 http://dx.doi.org/10.4168/aair.2021.13.5.681 |
| work_keys_str_mv | AT kimsumin doesmonthlydupilumabtherapymaintainitsclinicalefficacyinmoderatetosevereatopicdermatitis AT parkchangook doesmonthlydupilumabtherapymaintainitsclinicalefficacyinmoderatetosevereatopicdermatitis |